3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: December 10, 2010
Period of Report: December 8, 2010
Accession Number: 0001325812-10-000039

View Document ↗ View on SEC.gov ↗